Plus Therapeutics DSO Ratio 2011-2026 | PSTV

Annual DSO Ratio Plus Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	71.1	68.5	20.7	14.6	41.5	41.1	65.3	128	102	103

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128	14.6	65.5

Quarterly DSO Ratio Plus Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	87.4	-	18.9	32.1	26	18.9	28.3	13.7	107	77.3	155	101	78.5	61.7	125	59.5	116	45.9	219	121	239	140	234	269	265	90.3	273	184	191	99.3	96.6	85.5	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
273	13.7	118

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Regeneron Pharmaceuticals REGN	152	$ 742.1	-1.93 %	$ 77.6 B	USA
AbbVie ABBV	258	$ 211.9	0.37 %	$ 375 B	USA
AbCellera Biologics ABCL	173	$ 3.28	-2.24 %	$ 980 M	Canada
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Rigel Pharmaceuticals RIGL	57.9	$ 26.28	-0.34 %	$ 473 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Arena Pharmaceuticals ARNA	946	-	-6.81 %	$ 3.04 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Avidity Biosciences RNA	45.1	$ 13.07	-0.23 %	$ 1.8 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Rhythm Pharmaceuticals RYTM	42.9	$ 77.56	-5.31 %	$ 5.04 B	USA
Avid Bioservices CDMO	45.6	-	-	$ 789 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Adaptive Biotechnologies Corporation ADPT	60.7	$ 12.27	-12.11 %	$ 1.86 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
SIGA Technologies SIGA	47.1	$ 5.36	7.96 %	$ 383 M	USA
SELLAS Life Sciences Group SLS	72	$ 4.47	-9.69 %	$ 487 M	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Summit Therapeutics SMMT	379	$ 16.59	-3.88 %	$ 12.4 B	Britain